Thomson Reuters Thomson Pharma




Have your say on Thomson Pharma

Your comments, ideas and suggestions

If you’d like to provide feedback, or highlight an area in which
Thomson Pharma could be developed that would be useful to you, please complete the form below.

A good knowledge solution isn’t just about the information it provides. It’s also about the user experience — the features and functionality that make it quick and easy to find the content you need.

The feedback you provide will help us to enhance the content and user experience of Thomson Pharma to match your way of working. We’re interested in hearing not just from registered users, but from those thinking of subscribing to Thomson Pharma, or who use a competitor’s product.

Join the Thomson Pharma Usability Group

Why not join our Usability Group? We’ll give you exclusive input into pre-launch developments, and invite you to help steer product enhancements and usability improvements. You don’t need to be a registered user and there’s no obligation to be part of a test group.

The Thomson Pharma Usability Group is just part of our commitment to driving usability excellence throughout Thomson Reuters.

For further information, please click the checkbox in the form below.

* Compulsory fields
       
 
First Name*:
 
       
 
Last Name*:
 
       
 
Company*:
 
       
 
Job Title*:
 
       
 
Department:
 
       
 
E-mail*:
 
       

       
  Yes, I would like to join your Usability Group
       
 
Feedback type:
 
       
 
Comments:
 



The Scientific business of Thomson Reuters would like to keep you up to date with developments to our products and services. We would also like to invite you to special events such as seminars and receptions, and we would like you to benefit from our free newsletters and other resources.

  Yes, I would like to receive further information from the Scientific business of Thomson Reuters
  No, I do not want to receive further information from the Scientific business of Thomson Reuters.

Find out more about brands from the Scientific business of Thomson Reuters.

For information about our privacy policies or to change your communications preferences, please refer to our Privacy Statement.





Disclaimer | Terms of Use
Privacy Policy | Copyright